biostudies-literatureBatlle MFondo Europeo de Desarrollo Regional (FEDER)Spanish Network on Heart Failure REDINSCORRed de Investigaciones Cardiovasculares RICFundació la Marató de TV3 2008Retos-Colaboración 2015Ministerio de Economía y CompetitividadInstituto de Salud Carlos III, Ministerio de Sanidad y Consum876-882https://www.ebi.ac.uk/biostudies/studies/S-EPMC5109253biostudies-literatureUnknown9In this article, the full description of a heart failure with reduced ejection fraction (HF_REF) cohort of 192 patients is provided. Tables with the baseline demographic, prior history, ECG parameters, echocardiographic parameters, laboratory values and pharmacological treatment of these patients are included. Also, the quartile values of the analyzed circulating biomarkers: high sensitivity Troponin T (hs-TnT), galectin-3 (Gal-3), C-terminal propeptide of type I procollagen (CICP), soluble AXL (sAXL) and Brain Natriuretic Peptide (BNP) are given. The main demographic and clinical features of the patients' subgroups that have hs-TnT, Gal-3, CICP or BNP above the third quartile are described. Tables with Pearson correlation analysis of the HF_REF patients' biomarker levels are included. AndData in briefData on clinical characteristics of a heart failure patients' cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP.PMC5109253project 080121RD12/0042project 081010RTC-2015–4184-1V-2006-RET0308-ORamirez JOrtiz JCardona MBedini JLde Frutos PGSabate MPerez-Villa FCampos BFarrero MCastel MAPulgarin MJRoig EBatlle MGonzalez BfalseData on clinical characteristics of a heart failure patients' cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP.In this article, the full description of a heart failure with reduced ejection fraction (HF_REF) cohort of 192 patients is provided. Tables with the baseline demographic, prior history, ECG parameters, echocardiographic parameters, laboratory values and pharmacological treatment of these patients are included. Also, the quartile values of the analyzed circulating biomarkers: high sensitivity Troponin T (hs-TnT), galectin-3 (Gal-3), C-terminal propeptide of type I procollagen (CICP), soluble AXL (sAXL) and Brain Natriuretic Peptide (BNP) are given. The main demographic and clinical features of the patients' subgroups that have hs-TnT, Gal-3, CICP or BNP above the third quartile are described. Tables with Pearson correlation analysis of the HF_REF patients' biomarker levels are included. And2016-01-01T00:00:00Z2016 Dec2025-04-05T15:56:15.768Z2019-03-27T02:28:58ZS-EPMC51092532787288410.1016/j.dib.2016.10.020